Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38αMAPK inhibitors in Werner syndrome cells

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

A benzopyranopyridine inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MK2) is prepared rapidly and efficiently in one step using microwave dielectric heating, whereas a substrate-selective p38 MAPK inhibitor was prepared using conventional heating techniques. The former had MK2 inhibitory activity above 2.5 microM concentration, whereas the latter showed no MK2 inhibition at 10 microM. However, rather than rescuing the reduced cellular growth rate and aged morphology of hTERT-immortalised WS dermal fibroblasts, both induce a state resembling stress-induced cellular senescence, suggesting that these inhibitors may have limited therapeutic use.

Knowledge Graph

Similar Paper

Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38αMAPK inhibitors in Werner syndrome cells
Bioorganic & Medicinal Chemistry Letters 2007.0
Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells
Bioorganic & Medicinal Chemistry Letters 2007.0
Pyridinylquinoxalines and Pyridinylpyridopyrazines as Lead Compounds for Novel p38α Mitogen-Activated Protein Kinase Inhibitors
Journal of Medicinal Chemistry 2010.0
Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells
Bioorganic & Medicinal Chemistry Letters 2013.0
Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors
Journal of Medicinal Chemistry 2019.0
Design, Synthesis, and Biological Evaluation of Novel Disubstituted Dibenzosuberones as Highly Potent and Selective Inhibitors of p38 Mitogen Activated Protein Kinase
Journal of Medicinal Chemistry 2012.0
Synthesis and biological evaluation of p38α kinase-targeting dialkynylimidazoles
Bioorganic & Medicinal Chemistry Letters 2009.0
Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity
Journal of Medicinal Chemistry 2013.0
Unexpected Reaction of 2-Alkylsulfanylimidazoles to Imidazol-2-ones: Pyridinylimidazol-2-ones as Novel Potent p38α Mitogen-Activated Protein Kinase Inhibitors
Journal of Medicinal Chemistry 2010.0
Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitor
Bioorganic & Medicinal Chemistry Letters 2002.0